About 2 400 reports

China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Monoclonal Antibody
  • China
  • Biologics Sales
  • Industrial Production

Abstract: - Global Monoclonal Antibodies Market to Reach $142.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Monoclonal Antibodies estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$142.2 Billion by 2027, growing at a CAGR of 5.1% over the analysis period...

  • Monoclonal Antibody
  • World
  • China
  • United States

The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; it is expected to grow at a CAGR of 11.8% from 2021 to 2028. The increasing prevalence of cancer and other chronic diseases and the growing cases of COVID-19 across various regions are the factors supporting the market proliferation....

  • Monoclonal Antibody
  • World
  • APAC
  • Health Expenditure
  • Gross Domestic Product

Major players in the conjugated monoclonal antibodies market are Pfizer Inc., F. Hoffmann-LA, Bristol -Myers Squibb, Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., and Spectrum Pharmaceuticals Inc. The global conjugated monoclonal...

  • Monoclonal Antibody
  • Biopharmaceutical
  • World
  • Japan
  • Middle East
  • United States
  • APAC
  • United Kingdom

Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics and Intas Pharmaceuticals Limited. The global biosimilar monoclonal antibodies market is expected to grow from $4.51 billion in 2021 to $5.47 billion...

  • Monoclonal Antibody
  • Biopharmaceutical
  • United States
  • Biosimilar Approvals
  • Chronic Disease Prevalence

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC. and Mylan N.V. The global arthritis monoclonal antibodies market is expected to grow from $44.14 billion in 2021 to $49.44 billion in 2022 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co. and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to grow from $49.81 billion...

  • Monoclonal Antibody
  • World
  • Cancer Incidence
  • Cancer Mortality

Major players in the monoclonal antibodies (MABS) market are Johnson & Johnson, Merck, AbbVie, Amgen, GlaxoSmithKline plc., Norvatis AG, Pfizer Inc., Thermofischer Scientific, Elililly and Company and Bristol-Myers Squibb. The global monoclonal antibodies (mabs) market is expected to grow from $168.70 billion in 2021 to $188.18 billion...

  • Monoclonal Antibody
  • World
  • India
  • Biologics Sales
  • Retail Revenue

Global Monoclonal Antibodies Market 2021-2025 The analyst has been monitoring the monoclonal antibodies market and it is poised to grow by $ 63.41 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. Our report on monoclonal antibodies market provides a holistic analysis, market size and forecast,...

  • Monoclonal Antibody
  • World

Global Cancer Monoclonal Antibodies Market 2021-2025 The analyst has been monitoring the cancer monoclonal antibodies market and it is poised to grow by $ 33.1 bn during 2021-2025, progressing at a CAGR of 8.23% during the forecast period. Our report on cancer monoclonal antibodies market provides a holistic analysis, market...

  • Monoclonal Antibody
  • World

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $15.37 billion in 2021 to $16.67 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

The Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021 report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors...

  • Monoclonal Antibody
  • World

The global biosimilars market is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising incidence of chronic diseases and increasing demand of biosimilars for their cost-effectiveness. Regulatory approvals and other...

  • Biopharmaceutical
  • Monoclonal Antibody
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Biosimilar Penetration Rate
  • Drug Approval

Global Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 The analyst has been monitoring the biosimilar monoclonal antibodies (mAbs) market and it is poised to grow by $ 3.48 bn during 2021-2025, progressing at a CAGR of 14.05% during the forecast period. Our report on the biosimilar monoclonal antibodies (mAbs)...

  • Monoclonal Antibody
  • Biosimilar
  • World
  • Chronic Disease Prevalence

The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022 report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Most active companies...

  • Monoclonal Antibody
  • World

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2022-2026 The analyst has been monitoring the anti-CD20 monoclonal antibodies (mABs) market and it is poised to grow by $ 9.05 bn during 2022-2026 progressing at a CAGR of 9.81% during the forecast period. Our report on the anti-cd20 monoclonal antibodies (mABs) market...

  • Monoclonal Antibody
  • World

The custom antibody market in Europe is expected to grow from US$ 102.5 million in 2021 to US$ 213.7 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Advancements in medical technologies support faster and highly efficient discoveries in antibody development, which can be further customized as per the customers’...

  • Pharmaceutical
  • Monoclonal Antibody
  • Biotechnology
  • Infectious Disease
  • Drug Development
  • Polyclonal Antibody
  • Europe
  • Chronic Disease Prevalence
  • Cancer Incidence

The custom antibody market in South and Central America is expected to grow from US$ 23.9 million in 2021 to US$ 45.9 million by 2028; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028. Advancements in medical technologies support faster and highly efficient discoveries in antibody development, which can be further customized as...

  • Monoclonal Antibody
  • Infectious Disease
  • Biotechnology
  • Central America
  • Foreign Direct Investment
  • Cancer Incidence

The global biopharmaceuticals market is found witnessing a CAGR of 7.32%. The market is largely driven by the growing geriatric population, increasing burden of chronic diseases, and rising inclination toward targeted therapy. Also, the huge demand of biopharmaceutical is facilitated by an accelerating focus in research and related investment. The...

  • Biopharmaceutical
  • Monoclonal Antibody
  • Infectious Disease
  • Vaccine
  • Protein Therapy
  • Biotech Vaccine
  • APAC
  • Health Expenditure
  • Drug Approval

Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co., and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to grow from $45.51 billion...

  • Monoclonal Antibody
  • World
  • United States
  • Cancer Incidence
  • Cancer Mortality

Major players in the conjugated monoclonal antibodies market are Pfizer Inc., F. Hoffmann-LA, Bristol -Myers Squibb, Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., and Spectrum Pharmaceuticals Inc. The global conjugated monoclonal...

  • Monoclonal Antibody
  • Biopharmaceutical
  • World
  • United States
  • Japan
  • APAC
  • United Kingdom

Major players in the biosimilar monoclonal antibodies market are Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics, and Intas Pharmaceuticals Limited. The global biosimilar monoclonal antibodies market is expected to grow from $3.52 billion in 2020 to $4.33 billion...

  • Biopharmaceutical
  • Monoclonal Antibody
  • United States
  • Biosimilar Approvals
  • Chronic Disease Prevalence

Cancer Monoclonal Antibodies market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Cancer Monoclonal Antibodies Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Cancer Monoclonal Antibodies types, applications....

  • Monoclonal Antibody
  • World

Monoclonal Antibody Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Monoclonal Antibody Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Monoclonal Antibody Therapeutics types,...

  • Monoclonal Antibody
  • Therapy
  • World

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc, AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, and Mylan N.V. The global arthritis monoclonal antibodies market is expected to grow from $44.82 billion in 2020 to $48.08 billion in 2021 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $12.67 billion in 2020 to $13.76 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, and Human), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, and Others), and End User (Hospitals, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global monoclonal...

  • Monoclonal Antibody
  • World

The global cancer monoclonal antibodies market exhibited moderate growth during 2015-2020. A cancer monoclonal antibody refers to a laboratory-generated molecule that is engineered to mimic the immune system’s attack on cancer cells. It can bind to antigens present on the surface of cancer cells and flag them to trigger...

  • Monoclonal Antibody
  • World

Antibodies Contract Manufacturing Market- Scope of Report The latest publication on the antibodies contract manufacturing market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.The study offers detailed insights on...

  • Monoclonal Antibody
  • Asia
  • Africa

Major players in the monoclonal antibodies (MABS) market are Johnson & Johnson, Merck, AbbVie, Amgen, and GlaxoSmithKline plc. The global monoclonal antibodies (mabs) market is expected to grow from $106.87 billion in 2020 to $114.43 billion in 2021 at a compound annual growth rate (CAGR) of 7.1%. The growth is mainly due to the companies...

  • Monoclonal Antibody
  • World
  • India
  • United States
  • Biologics Sales
  • Retail Revenue